Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Piper Sandler Upgrades Claritev to Overweight, Raises Price Target to $44

Author: Benzinga Newsdesk | May 29, 2025 11:47am
Piper Sandler analyst Jessica Tassan upgrades Claritev (NYSE:CTEV) from Neutral to Overweight and raises the price target from $19 to $44.

Posted In: CTEV

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist